Home › Partial Epilepsies › Pennsylvania › Philadelphia
Partial Epilepsies clinical trials in Philadelphia, PA
3 studies for Partial Epilepsies are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
RecruitingPhase 2
- Thomas Jefferson University, Philadelphia
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
RecruitingPhase 3
- Thomas Jefferson University, Philadelphia
A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures
RecruitingPhase 2
- University of Pennsylvania - Department of Neurology, Philadelphia
Partial Epilepsies trials in other cities
- Washington, DC4 studies
- Houston, TX4 studies
- Cleveland, OH3 studies
- New York City, NY3 studies
- Nashville, TN3 studies
- Rochester, MN3 studies
Other studies in Philadelphia
- Cancer (all types)59 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Prostate Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer28 studies
- Depression26 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.